DMAA Conviction, FTC Settlement: Health And Wellness Regulatory News
This article was originally published in The Rose Sheet
You may also be interested in...
UAS Labs Expands Probioitic Portfolio: Health And Wellness Industry News
UAS Labs acquires Nebraska Cultures; ingredient supplier guilty in FDA undercover investigation; FTC cuts checks for bogus memory pill refunds; diaper rash cream recall; and kratom recall updates.
Five Shanghai Suspects Charged After FDA Undercover Work On Spiked Supplements
One of the undeclared stimulant ingredients, 2-amino-6-methylheptane, or DMHA, is new on FDA's radar for violative ingredients used in products marketed as dietary supplements, while the other, 1,3-dimethylamylamine, DMAA, has long been a target of agency enforcement in the supplement sector.
FTC Takes On 'Labyrinth' Behind Deceptive Tooth Whitener 'Trial' Offers
The Federal Trade Commission is making good on its promise to crack down on illegal negative option billing practices, targeting a scheme involving nearly 80 companies and 90 websites that lured unwitting consumers into paying up to $200 every month for what initially was presented as a low-cost trial "reward."